RESEARCH
A new golden age of science?
Chip Somodevilla/Getty Images
Science advocates have spent 18 months accusing the Trump administration of what they see as shredding the existing social contract between academic researchers and the federal government, a relationship that made the United States the world’s most powerful engine of discovery. Now, the administration has a proposal to update that relationship.
Trump science adviser Michael Kratsios, who is not a scientist, has published a report that he hopes will usher in “A New Golden Age.” It calls for new grant funding mechanisms, embraces an ethos of funding people rather than projects, and pushes an image of innovation that centers industry over academia.
STAT’s Anil Oza breaks down the report and critics’ opinions of the document. Who called the report a “banger”? Read the story.
DISABILITY
Autism advisory committees clash over priorities
Two similarly-named groups have spent months publicly sniping at each other as they jockey for sole authority on research into and funding for autism spectrum disorder.
Last week, the federally-appointed body — the Interagency Autism Coordinating Committee — published a dense, 336-page strategic plan that the public had four days to review and leave comments. Several autism advocacy groups called for the comment window to be extended to 90 days, in response. The committee’s report will eventually head to Kennedy and Congress to help coordinate roughly $2 billion in federal funding for autism research and training programs, and they were slated to meet on July 31 to vote on the plan’s recommendations before postponing the meeting late Thursday.
The plan spends most of its pages discussing potential environmental factors for autism, even though the condition is overwhelmingly genetic in origin, and also discusses strategies to help people with profound autism.
What is profound autism? Depends who you ask, though it’s broadly considered to be autistic people with high support needs. But the federal body’s definition of this population diverges from prior definition, and the Independent Autism Coordinating Committee spent a chunk of its meeting yesterday discussing its own definition and plans to help that population. To quote Rep. Alexandria Ocasio-Cortez (D-N.Y.), the girls are fighting.
Which definition will win out? Stay tuned for the federal group’s eventual meeting. But as one member of the independent committee put it yesterday, “I think as a committee, we are quite lacking in resources.”
DRUGS
Where in the world is my insulin pen?
People with diabetes are in a bind as they encounter supply issues for their long-acting insulin pen made by Sanofi.
The Lantus Solostar pen containing 3 milliliters of insulin glargine has been running low for several weeks, though the issue is not technically considered a shortage by the Food and Drug Administration. Nonetheless, patients are having trouble getting the medication, as large pharmacies like CVS and Walgreens lose their stock.
Pharmacists are rushing to manage prescriptions within the bounds of what a patient’s insurance and condition will allow. Read more about the shortage from STAT’s Isabella Cueto.
